Increased tumor proliferation induced by the secretome was associated most prominently with activation of the AKT pathway, and dual inhibition of the RAF and the PI3K/AKT/mTOR signaling pathways reduced the growth of drug-resistant cells in a BRAF-mutant melanoma model [86]. Here, AKT1 is linked to melanoma.